Hashimoto's encephalopathy: A rare proteiform disorder

Autoimmunity Reviews

Volumn 15, Issue 5, 2016, Pages 466-476

  Montagna, Giacomo ^a   Imperiali, Mauro ^a   Agazzi, Pamela ^a   D'Aurizio, Federica ^b   Tozzoli, Renato ^b   Feldt Rasmussen, Ulla ^c   Giovanella, Luca ^d  

^a REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^c Mental Health Center Glostrup   (Denmark)

^d ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Anti thyroperoxidase antibodies; Anti enolase antibodies; Autoimmune encephalopathies; Autoimmune thyroid diseases; Hashimoto's encephalopathy

Indexed keywords

ADOLESCENT; BIBLIOGRAPHIC DATABASE; CASE REPORT; COGNITIVE DEVELOPMENT; DISEASE ASSOCIATION; DISEASE MARKER; EPILEPTIC STATE; HASHIMOTO ENCEPHALOPATHY; HUMAN; HYPOTHYROIDISM; INTENSIVE CARE; LABORATORY TEST; MALE; MEDICAL HISTORY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RESTLESSNESS; REVIEW; SEDATION; STEROID THERAPY; TONIC CLONIC SEIZURE; COGNITION DISORDERS; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; HASHIMOTO DISEASE; IMMUNOLOGY; TREATMENT OUTCOME;

AUTOANTIGEN; BIOLOGICAL MARKER; IODIDE PEROXIDASE; IRON BINDING PROTEIN; STEROID; TPO PROTEIN, HUMAN;

AUTOANTIGENS; BIOMARKERS; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; STEROIDS; TREATMENT OUTCOME;

EID: 84958191389     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.01.014     Document Type: Review

References (115)

1. Watemberg N., Greenstein D., Levine A. Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J Child Neurol 2006, 21:1-5.
2. Rallison M.L., Dobyns B.M., Keating F.R., Rall J.E., Tyler F.H. Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr 1975, 86:675-682.
3. Antonelli A., Ferrari S.M., Corrado A., Di Domenicantonio A., Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev 2015, 14:174-180.
4. Caturegli P., De Remigis A., Rose N.R. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 2014, 13:391-397.
5. Nandi-Munshi D., Taplin C.E. Thyroid-related neurological disorders and complications in children. Pediatr Neurol 2015, 52:373-382.
6. Brain L., Jellinek E.H., Ball K. Hashimoto's disease and encephalopathy. Lancet 1966, 2:512-514.
7. Shaw P.J., Walls T.J., Newman P.K., Cleland P.G., Cartlidge N.E. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers-report of 5 cases. Neurology 1991, 41:228-233.
8. Canton A., de Fabregas O., Tintore M., Mesa J., Codina A., Simo R. Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition?. J Neurol Sci 2000, 176:65-69.
9. Sawka A.M., Fatourechi V., Boeve B.F., Mokri B. Rarity of encephalopathy associated with autoimmune thyroiditis: a case series from Mayo Clinic from 1950 to 1996. Thyroid 2002, 12:393-398.
10. Ferracci F., Bertiato G., Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci 2004, 217:165-168.
11. Ferracci F., Carnevale A. The neurological disorder associated with thyroid autoimmunity. J Neurol 2006, 253:975-984.
12. Castro-Gago M., Gomez-Lado C., Maneiro-Freire M., Eiris-Punal J., Bravo-Mata M. Hashimoto encephalopathy in a preschool girl. Pediatr Neurol 2010, 42:143-146.
13. Seipelt M., Zerr I., Nau R., Mollenhauer B., Kropp S., Steinhoff B.J., et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1999, 66:172-176.
14. Hilberath J.M., Schmidt H., Wolf G.K. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): case report of reversible coma and status epilepticus in an adolescent patient and review of the literature. Eur J Pediatr 2014, 173:1263-1273.
15. Mocellin R., Walterfang M., Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 2007, 21:799-811.
16. Deutsch M., Koskinas J., Tzannos K., Vassilopoulos D., Mailis A., Tolis G., et al. Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin. Ann Pharmacother 2005, 39:1745-1748.
17. Nagamine M., Yoshino A., Ishii M., Ogawa T., Kurauchi S., Yoshida T., et al. Lithium-induced Hashimoto's encephalopathy: a case report. Bipolar Disord 2008, 10:846-848.
18. Sellal F., Berton C., Andriantseheno M., Clerc C. Hashimoto's encephalopathy: exacerbations associated with menstrual cycle. Neurology 2002, 59:1633-1635.
19. Ishii K., Hayashi A., Tamaoka A., Mizusawa H., Shoji S. A case of Hashimoto's encephalopathy with a relapsing course related to menstrual cycle. Rinsho Shinkeigaku 1993, 33:995-997.
20. Hori T., Oike F., Hata K., Nishikiori M., Ogura Y., Ogawa K., et al. Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein-Barr virus infection. Transpl Infect Dis 2010, 12:347-352.
21. Castillo P., Woodruff B., Caselli R., Vernino S., Lucchinetti C., Swanson J., et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006, 63:197-202.
22. Kothbauer-Margreiter I., Sturzenegger M., Komor J., Baumgartner R., Hess C.W. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 1996, 243:585-593.
23. Ghika-Schmid F., Ghika J., Regli F., Dworak N., Bogousslavsky J., Stadler C., et al. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?. Mov Disord 1996, 11:555-562.
24. Afshari M., Afshari Z.S., Schuele S.U. Pearls & oy-sters: Hashimoto encephalopathy. Neurology 2012, 78:e134-e137.
25. Chong J.Y., Rowland L.P., Utiger R.D. Hashimoto encephalopathy: syndrome or myth?. Arch Neurol 2003, 60:164-171.
26. Marshall G.A., Doyle J.J. Long-term treatment of Hashimoto's encephalopathy. J Neuropsychiatr Clin Neurosci 2006, 18:14-20.
27. Chaudhuri A., Behan P.O. The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto's encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem 2003, 10:1945-1953.
28. Tamagno G., Celik Y., Simo R., Dihne M., Kimura K., Gelosa G., et al. Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes. BMC Neurol 2010, 10:27.
29. de Holanda N.C., de Lima D.D., Cavalcanti T.B., Lucena C.S., Bandeira F. Hashimoto's encephalopathy: systematic review of the literature and an additional case. J Neuropsychiatr Clin Neurosci 2011, 23:384-390.
30. Salpietro V., Mankad K., Polizzi A., Sugawara Y., Granata F., David E., et al. Pediatric Hashimoto's encephalopathy with peripheral nervous system involvement. Pediatr Int 2014, 56:413-416.
31. Cao N.J., Tselis A.C., Li J., Gorman M. A case of Hashimoto's encephalopathy: association with sensory ganglionopathy. J Neurol Sci 2005, 238:105-107.
32. Bairactaris C., Stouraitis G., Papalias E., Fakas N., Papatheodorou G., Gourtzelidis P. Early neurophysiological evolution of chronic inflammatory demyelinating polyneuropathy in a patient with Hashimoto's thyroiditis. Muscle Nerve 2008, 38:1518-1522.
33. Azuma T., Uemichi T., Funauchi M., Doi S., Matsubara T. Myelopathy associated with Hashimoto's disease. J Neurol Neurosurg Psychiatry 2000, 68:681-682.
34. Carlone C., Todini L., Marini I., Majorana M., Casciato S., Giallonardo A.T., et al. Acute psychiatric presentation of steroid-responsive encephalopathy: the under recognized side of autoimmune thyroiditis. Riv Psichiatr 2013, 48:169-173.
35. Wilcox R.A., To T, Koukourou A., Frasca J. Hashimoto's encephalopathy masquerading as acute psychosis. J Clin Neurosci 2008, 15:1301-1304.
36. Mahmud F.H., Lteif A.N., Renaud D.L., Reed A.M., Brands C. Steroid-responsive encephalopathy associated with Hashimoto's thyroiditis in an adolescent with chronic hallucinations and depression: case report and review. Pediatrics 2003, 112:686-690.
37. Nunnemann C., Kratz T. Hashimoto encephalopathy-a difficult differential diagnosis. A case report of reversible dementia and psychosis. Fortschr Neurol Psychiatr 2008, 76:610-615.
38. Santoro D., Colombo I., Ghione I., Peverelli L., Bresolin N., Sciacco M., et al. Steroid-responsive Hashimoto encephalopathy mimicking Creutzfeldt-Jakob disease. Neurol Sci 2011, 32:719-722.
39. Prat S., Jouan Y., Magnant J., Graux J., El-Hage W. Hashimoto encephalopathy diagnosis after 40 years of a schizophrenia-like disorder. Schizophr Res 2012, 139:269-270.
40. Vasconcellos E., Pina-Garza J.E., Fakhoury T., Fenichel G.M. Pediatric manifestations of Hashimoto's encephalopathy. Pediatr Neurol 1999, 20:394-398.
41. Voll R. Die unerkannte Hashimoto-enzephalopathie (undetected Hashimoto encephalopathy-a diagnostic challenge in child psychiatry and child neurology). Z Kinder Jugendpsychiatr Psychother 2010, 38:21-27.
42. Alink J., de Vries T.W. Unexplained seizures, confusion or hallucinations: think Hashimoto encephalopathy. Acta Paediatr 2008, 97:451-453.
43. Cook M.K., Malkin M., Karafin M.S. The use of plasma exchange in Hashimoto's encephalopathy: a case report and review of the literature. J Clin Apher 2015, 30:188-192.
44. Janes S.E., Santosh B., Thomas D., Vyas H. Hashimoto's encephalopathy: an unusual cause of seizures in the intensive care unit. Pediatr Crit Care Med 2004, 5:578-581.
45. Gayatri N.A., Whitehouse W.P. Pilot survey of Hashimoto's encephalopathy in children. Dev Med Child Neurol 2005, 47:556-558.
46. Huang W., Xia C., Chatham M. Infectious disease or Hashimoto's encephalopathy flares: a case report. Seizure 2011, 20:717-719.
47. Papathanasopoulos P., Mallioris K., Karanasios P., Dimopoulos D., Papapetropoulos T. Febrile Hashimoto's encephalopathy. J Neurol Neurosurg Psychiatry 2000, 68:795.
48. Bonmann E., Prumbaum M., Stippich C., Ringleb P., Sliwka U. Hashimoto encephalopathy: rare cause of stroke in young patient. Neurologist 2009, 15:342-344.
49. Ferracci F., Moretto G., Candeago R.M., Cimini N., Conte F., Gentile M., et al. Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy. Neurology 2003, 60:712-714.
50. Tsai S.L., Lewis E.C., Sell E., Whiting S. Central nervous system vasculitis with positive antithyroid antibodies in an adolescent boy. Pediatr Neurol 2011, 45:189-192.
51. Nolte K.W., Unbehaun A., Sieker H., Kloss T.M., Paulus W. Hashimoto encephalopathy: a brainstem vasculitis?. Neurology 2000, 54:769-770.
52. Shibata N., Yamamoto Y., Sunami N., Suga M., Yamashita Y. Isolated angiitis of the CNS associated with Hashimoto's disease. Rinsho Shinkeigaku 1992, 32:191-198.
53. Duffey P., Yee S., Reid I.N., Bridges L.R. Hashimoto's encephalopathy: postmortem findings after fatal status epilepticus. Neurology 2003, 61:1124-1126.
54. Schiess N., Pardo C.A. Hashimoto's encephalopathy. Ann N Y Acad Sci 2008, 1142:254-265.
55. Moodley K., Botha J., Raidoo D.M., Naidoo S. Immuno-localisation of anti-thyroid antibodies in adult human cerebral cortex. J Neurol Sci 2011, 302:114-117.
56. Kabelitz M., Liesenkotter K.P., Stach B., Willgerodt H., Stablein W., Singendonk W., et al. The prevalence of anti-thyroid peroxidase antibodies and autoimmune thyroiditis in children and adolescents in an iodine replete area. Eur J Endocrinol 2003, 148:301-307.
57. Quinn F.A., Tam M.C., Wong P.T., Poon P.K., Leung M.S. Thyroid autoimmunity and thyroid hormone reference intervals in apparently healthy Chinese adults. Clin Chim Acta 2009, 405:156-159.
58. Hoogendoorn E.H., Hermus A.R., de Vegt F., Ross H.A., Verbeek A.L., Kiemeney L.A., et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006, 52:104-111.
59. Vanderpump M.P., Tunbridge W.M., French J.M., Appleton D., Bates D., Clark F., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 1995, 43:55-68.
60. Zophel K., Saller B., Wunderlich G., Gruning T., Koch R., Wilde J., et al. Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: implications for the definition of TPOAb reference intervals. Clin Lab 2003, 49:591-600.
61. Oide T., Tokuda T., Yazaki M., Watarai M., Mitsuhashi S., Kaneko K., et al. Anti-neuronal autoantibody in Hashimoto's encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients. J Neurol Sci 2004, 217:7-12.
62. Fujii A., Yoneda M., Ito T., Yamamura O., Satomi S., Higa H., et al. Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy. J Neuroimmunol 2005, 162:130-136.
63. Yoneda M., Fujii A., Ito A., Yokoyama H., Nakagawa H., Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy. J Neuroimmunol 2007, 185:195-200.
64. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001, 58:902-920.
65. Ochi H., Horiuchi I., Araki N., Toda T., Araki T., Sato K., et al. Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy. FEBS Lett 2002, 528:197-202.
66. Miles L.A., Dahlberg C.M., Plescia J., Felez J., Kato K., Plow E.F. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 1991, 30:1682-1691.
67. Gini B., Lovato L., Cianti R., Cecotti L., Marconi S., Anghileri E., et al. Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach. J Neuroimmunol 2008, 196:153-158.
68. Archambeaud F., Galinat S., Regouby Y., Magy L., Rebeyrotte I., Vallat J.M., et al. Hashimoto encephalopathy. analysis of four case reports. Rev Med Interne 2001, 22:653-659.
69. Boers P.M., Colebatch J.G. Hashimoto's encephalopathy responding to plasmapheresis. J Neurol Neurosurg Psychiatry 2001, 70:132.
70. Kaya M., Cermik T.F., Bedel D., Kutucu Y., Tuglu C., Yigitbasi O.N. Assessment of alterations in regional cerebral blood flow in patients with hypothyroidism due to Hashimoto's thyroiditis. J Endocrinol Investig 2007, 30:491-496.
71. Kinuya S., Michigishi T., Tonami N., Aburano T., Tsuji S., Hashimoto T. Reversible cerebral hypoperfusion observed with Tc-99m HMPAO SPECT in reversible dementia caused by hypothyroidism. Clin Nucl Med 1999, 24:666-668.
72. Peschen-Rosin R., Schabet M., Dichgans J. Manifestation of Hashimoto's encephalopathy years before onset of thyroid disease. Eur Neurol 1999, 41:79-84.
73. Payer J., Petrovic T., Baqi L., Lisy L., Langer P. Hashimoto's encephalopathy and rare cases of hyperthyroidism (review and case report). Endocr Regul 2009, 43:169-178.
74. Schauble B., Castillo P.R., Boeve B.F., Westmoreland B.F. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 2003, 114:32-37.
75. Vander T., Hallevy C., Alsaed I., Valdman S., Ifergane G., Wirguin I. 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy. J Neurol 2004, 251:1273-1274.
76. Hernandez Echebarria L.E., Saiz A., Graus F., Tejada J., Garcia J.M., Clavera B., et al. Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy. Neurology 2000, 54:1539-1540.
77. Fatourechi V. Hashimoto's encephalopathy: myth or reality? An endocrinologist's perspective. Best Pract Res Clin Endocrinol Metab 2005, 19:53-66.
78. Forchetti C.M., Katsamakis G., Garron D.C. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology 1997, 49:623-626.
79. Lee S.W., Donlon S., Caplan J.P. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) or Hashimoto's encephalopathy: a case and review. Psychosomatics 2011, 52:99-108.
80. Pedroso J.L., Knobel M., Barsottini O.G., Caboclo L.O., Knobel E. The relevance of electroencephalogram as a follow-up test in Hashimoto encephalopathy course after corticosteroids therapy. Acta Neurol Belg 2012, 112:409-411.
81. Song Y.M., Seo D.W., Chang G.Y. MR findings in Hashimoto encephalopathy. AJNR Am J Neuroradiol 2004, 25:807-808.
82. Zimmermann P., Stranzinger E. Steroid-responsive encephalopathy associated with Hashimoto thyroiditis. Pediatr Radiol 2012, 42:891-893.
83. McCabe D.J., Burke T., Connolly S., Hutchinson M. Amnesic syndrome with bilateral mesial temporal lobe involvement in Hashimoto's encephalopathy. Neurology 2000, 54:737-739.
84. Takahashi S., Mitamura R., Itoh Y., Suzuki N., Okuno A. Hashimoto encephalopathy: etiologic considerations. Pediatr Neurol 1994, 11:328-331.
85. Bohnen N.I., Parnell K.J., Harper C.M. Reversible MRI findings in a patient with Hashimoto's encephalopathy. Neurology 1997, 49:246-247.
86. Rossler M., Klotz J.M. Celebral vasculitis and autoimmune thyreoiditis. Fortschr Neurol Psychiatr 2008, 76:166-169.
87. Becker H., Hofmann M., von Einsiedel H., Conrad B., D.Sander Circumscribed vasculitis with posterior infarct in Hashimoto encephalopathy. Nervenarzt 2002, 73:376-379.
88. Tsai M.H., Lee L.H., Chen S.D., Lu C.H., Chen M.T., Chuang Y.C. Complex partial status epilepticus as a manifestation of Hashimoto's encephalopathy. Seizure 2007, 16:713-716.
89. Bertoni M., Falcini M., Sestini S., Niccoli L., Nannini C., Cantini F. Encephalopathy associated with Hashimoto's thyroiditis: an additional case. Eur J Intern Med 2003, 14:434-437.
90. Piga M., Serra A., Deiana L., Loi G.L., Satta L., Di Liberto M., et al. Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis. Eur J Nucl Med Mol Imaging 2004, 31:1639-1644.
91. Pari E., Rinaldi F., Premi E., Codella M., Rao R., Paghera B., et al. A follow-up (1)(8)F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis. J Neurol 2014, 261:663-667.
92. Zettinig G., Asenbaum S., Fueger B.J., Hofmann A., Diemling M., Mittlboeck M., et al. Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis?. Clin Endocrinol 2003, 59:637-643.
93. Doherty C.P. Possibly, probably definitely, Hashimoto encephalopathy. J Neurol Sci 2005, 228:1-2.
94. Tamagno G., Federspil G., Murialdo G. Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy). Intern Emerg Med 2006, 1:15-23.
95. Caselli R.J., Boeve B.F., Scheithauer B.W., O'Duffy J.D., Hunder G.G. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology 1999, 53:1579-1581.
96. Tamagno G., Gaoatswe G. Time for the endocrinologists to expand their awareness of and contribution to the diagnosis and management of encephalopathy associated with autoimmune thyroid disease. Hormones (Athens) 2011, 10:36-38.
97. Katoh N., Yoshida T., Shimojima Y., Gono T., Matsuda M., Yoneda M., et al. An 85-year-old case with Hashimoto's encephalopathy, showing spontaneous complete remission. Intern Med 2007, 46:1613-1616.
98. Mamoudjy N., Korff C., Maurey H., Blanchard G., Steshenko D., Loiseau-Corvez M.N., et al. Hashimoto's encephalopathy: identification and long-term outcome in children. Eur J Paediatr Neurol 2013, 17:280-287.
99. Yu H., Lee J., Seo D., Lee M. Clinical manifestations and treatment response of steroid in pediatric Hashimoto encephalopathy. J Child Neurol 2014, 29:938-942.
100. Olmez I., Moses H., Sriram S., Kirshner H., Lagrange A.H., Pawate S. Diagnostic and therapeutic aspects of Hashimoto's encephalopathy. J Neurol Sci 2013, 331:67-71.
101. Jacob S., Rajabally Y.A. Hashimoto's encephalopathy: steroid resistance and response to intravenous immunoglobulins. J Neurol Neurosurg Psychiatry 2005, 76:455-456.
102. Wirkowski E., Libman R.B., Batash M. Hashimot's encephalopathy-response to intravenous immunoglobulin. J Stroke Cerebrovasc Dis 1998, 7:265-266.
103. Cornejo R., Venegas P., Goni D., Salas A., Romero C. Successful response to intravenous immunoglobulin as rescue therapy in a patient with Hashimoto's encephalopathy. BMJ Case Rep 2010, 10.1136/bcr.09.2010.3332.
104. Gul Mert G., Horoz O.O., Herguner M.O., Incecik F., Yildizdas R.D., Onenli Mungan N., et al. Hashimoto's encephalopathy: four cases and review of literature. Int J Neurosci 2014, 124:302-306.
105. Nieuwenhuis L., Santens P., Vanwalleghem P., Boon P. Subacute Hashimoto's encephalopathy, treated with plasmapheresis. Acta Neurol Belg 2004, 104:80-83.
106. Hussain N.S., Rumbaugh J., Kerr D., Nath A., Hillis A.E. Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 2005, 64:165-166.
107. Zambrana J.L., Fuentes F., Rosa F., Velasco M.J. Hashimoto's disease presenting as encephalitis in a young woman. Am J Med 2002, 112:163-164.
108. Byrne O.C., Zuberi S.M., Madigan C.A., King M.D. Hashimoto's thyroiditis-a rare but treatable cause of encephalopathy in children. Eur J Paediatr Neurol 2000, 4:279-282.
109. McGinley J., McCabe D.J., Fraser A., Casey E., Ryan T., Murphy R. Hashimoto's encephalopathy; an unusual cause of status epilepticus. Ir Med J 2000, 93:118.
110. Mijajlovic M., Mirkovic M., Dackovic J., Zidverc-Trajkovic J., Sternic N. Clinical manifestations, diagnostic criteria and therapy of Hashimoto's encephalopathy: report of two cases. J Neurol Sci 2010, 288:194-196.
111. Fatemi S., Bedri J., Nicoloff J.T. Encephalopathy associated with Hashimoto's thyroiditis: use of serum immunoglobulin G as a marker of disease activity. Thyroid 2003, 13:227-228.
112. Galluzzi S., Geroldi C., Zanetti O., Frisoni G.B. Hashimoto's encephalopathy in the elderly: relationship to cognitive impairment. J Geriatr Psychiatry Neurol 2002, 15:175-179.
113. Erol I., Saygi S., Alehan F. Hashimoto's encephalopathy in children and adolescents. Pediatr Neurol 2011, 45:420-422.
114. Paterson R.W., Takada L.T., Geschwind M.D. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract 2012, 2:187-200.
115. Leypoldt F., Armangue T., Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci 2015, 1338:94-114.